oltipraz has been researched along with N-(4-Nitro-1,2,5-oxadiazol-3-yl)-2-pyridin-2-ylsulfanylacetamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade, CH; Braga, RC; Carpenter, AE; Dantas, RF; de Almeida, AC; Furnham, N; Kamentsky, L; Lima, EF; Melo-Filho, CC; Muratov, E; Neves, BJ; Paveley, R; Rezende-Neto, JM; Senger, MR; Silva-Junior, FP; Valente, WC | 1 |
1 other study(ies) available for oltipraz and N-(4-Nitro-1,2,5-oxadiazol-3-yl)-2-pyridin-2-ylsulfanylacetamide
Article | Year |
---|---|
Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening.
Topics: Animals; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Schistosoma mansoni; Schistosomiasis; Schistosomicides | 2016 |